Hormone replacement therapy for prevention or treatment of atherosclerosis in postmenopausal women: Promises, controversies, and clinical trials

American Journal of Geriatric Cardiology

Volumn 9, Issue 2, 2000, Pages 81-90

  Blum, A ^a   Koh, K ^a   Cannon III, R O ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PRAVASTATIN; RALOXIFENE; RECEPTOR BLOCKING AGENT; SIMVASTATIN; TAMOXIFEN;

AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOLYSIS; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION;

EID: 0033845412     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2000.80013.x     Document Type: Article

References (30)

1. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
2. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow-up from the Nurses' Health Study
3. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
4. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting
5. Estrogen replacement therapy after coronary angioplasty in postmenopausal women
6. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women
7. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
8. Effects of post-menopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
9. Effects of post-menopausal estrogen replacement on plasma Lp(a) concentrations
10. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
11. Beneficial effect of estrogen on exercised-induced myocardial ischaemia in women with coronary artery disease
12. Does sublingual 17β-oestradiol have any effects on exercise capacity and myocardial ischemia in post-menopausal women with stable coronary artery disease?
13. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
14. Acute vascular effects of estrogen in postmenopausal women
15. Estrogen improves endothelium dependent, flow-mediated vasodilation in postmenopausal women
16. Vascular effects of estrogen and cholesterol lowering therapies in hypercholesterolemic postmenopausal women
17. Esradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
18. The Coronary Drug Project: Initial findings leading to modifications of its research protocol
19. Risk of venous thromboembolism in users of hormone replacement therapy
20. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens
21. Prospective study of exogenous hormones and risk of pulmonary embolism in women
22. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study
23. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
24. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
25. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial
26. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
27. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
28. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
29. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
30. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels